Ver­tex paus­es di­a­betes islet cell ther­a­py study af­ter two pa­tient deaths it says are un­re­lat­ed to drug

Ver­tex has paused the Phase I/II study of its islet cell ther­a­py for type 1 di­a­betes fol­low­ing the death of two pa­tients, though the com­pa­ny …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.